Platelet Transfusion

Publication Date: November 28, 2017

Key Points

Key Points

Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.

Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.

Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.

Treatment

...eatment...

...of Platelet ProductsPlatelets for tr...


...f Rh AlloimmunizationUPDATED. Prevention...


...nUPDATED. The incidence of alloantibody-mediated...


...vs Therapeutic Platelet TransfusionProph...


...usion Threshold in Patients with Hematologic...


...nsfusion Threshold in the Setting of Hematopoi...


...telet Transfusion in Patients with Chronic,...


...ransfusion Threshold in Patients With Solid...


...t which Surgical or Invasive Procedures Ma...


...onitoring for Refractoriness to Platel...


...ctoriness to Platelet TransfusionAl...